Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, McNaughton E, Bracoud L, Ahmadi-Abhari S, de Wolf F, Anderson RM, Middleton LT; Alzheimer's Disease Neuroimaging Initiative.
McRae-McKee K, et al. Among authors: de wolf f.
Alzheimers Dement. 2019 Oct;15(10):1348-1356. doi: 10.1016/j.jalz.2019.07.010. Epub 2019 Sep 26.
Alzheimers Dement. 2019.
PMID: 31564609
Free article.
Review.